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Abstract: Numerous projects and industrial and academic col-
laborations benefit from state-of-the-art facilities and expertise
in analytical chemistry available at the Swiss Universities of
Applied Sciences. This review summarizes areas of expertise
in analytical sciences at the University of Applied Sciences
and Arts Northwestern Switzerland (FHNW), the University of
Applied Sciences and Arts Western Switzerland (HES-SO), and
the Zurich University of Applied Sciences (ZHAW). We briefly
discuss selected projects in different fields of analytical sci-
ences
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Introduction
Analytical platforms are highly interdisciplinary and are of
great importance to support all fields of research. The technol-
ogy and instrumentation, based on sophisticated and expensive
infrastructure, is as important as the experts who know how to
use, improve and optimize the techniques as well as to support
the interpretation of results. In the focus of the Universities of
Applied Science for education and research, it is important to
provide state-of-the-art technology to train students in applied
research and to support their own research projects. The main
difference to classical universities is the reduced need for cutting-
edge instrumentation for fundamental research (like ultra-high
field NMR spectrometers or ultra-high resolutionmass spectrom-
eters). Robust state-of-the-art technologies for business oriented
and applied research are needed instead. However, the analytical
platforms at the Universities of Applied Sciences in Switzerland
are extremely diverse according to their focus, purpose and
needs. The purely supporting platforms such as NMR- and mass
spec. services, which are run by dedicated experts within the in-
stitutions as a routine service, is one common approach. Another
setting is the distribution of instruments within each institute as
dedicated support for experts in other fields. This means for ex-
ample that researchers in organic chemistry run their own instru-
ments (e.g. HPLC, MS, NMR) to follow reactions and perform
quality control. Sometimes such platforms are partially orga-
nized as open-access facilities, where a dedicated teammaintains
instruments and each scientist uses these open-access systems on
a need basis.
Finally, there are independent multidisciplinary analytical
platforms that run their own instruments, perform their own
projects for method and instrument development and support
other teams inside and outside the institution with analytical
expertise and instrumentation. The techniques used in all these
fields where analytical platforms play a key role, as well as
how they are organized within the different institutions, is as
diverse as the different research and education models. This
article provides an overview of analytical platforms, projects
infrastructure and focus of the Universities of Applied Science
across Switzerland.
FHNW Muttenz
The School of Life Sciences conducts research and educa-
tion along the entire healthcare and value creation chain. The
spectrum ranges from the development of medical products and
drugs, technologies and production processes through to their
production and market launch. An additional focus is the devel-
opment of resource-saving technologies and environmental pro-
cedures. The research is organized within four institutes and each
runs its own infrastructure for analytical support, development
and training.
The institute forMedicalEngineeringandMedical Informatics
(IM2) needs mostly surface analytical tools (e.g. REM, ultra-
sound, X-ray diffraction) for the development of functional ma-
terials, implant design and Biofabrication (3D-Bioprinting).
The Institute of Pharma technology (IPT) conducts research
into new technologies and methods for pharmaceutical products.
The fields are bioprocess technology, drug delivery and PK/PD,
formulation and devices for active chemical and biological sub-
stances, oral formulations of chemical drugs and production pro-
cesses and techniques. Among other technologies, LC-MS and
capillary electrophoresis are used for quality control processes
and to investigate effects of drugs and formulations on organisms
within cell models. Neither IM2 nor IPT runs a dedicated analyti-
cal platform. Their instruments are specifically located among
the teams who need them as tools and use the other platforms of
the other institutes in collaboration.
The Institute for Ecopreneurship (IEC) for environment and
resources performs research and education in the fields of envi-
ronmental and water technologies, environmental biotechnology,
ecotoxicology and sustainable resources management. This insti-
tute provide the main platform for inorganic, elemental analysis
(e.g. LC-QQQ-ICP-MS, laser ablation, ICP-OES, µXRF, XRF,
SEM, EVO SEM). For organic analysis an additional platform
is present for direct support (e.g. LC, LC-OCD, LC-MSn - QqQ
and Ion Trap, GC-MS, MALDI-TOF). The radioisotope analysis
platform is also integrated within a specialized radiology labo-
ratory (14C and 3H, liquid scintillation, autoradiography, HPLC
with liquid scintillation detector, sample Oxidizer). Molecular bi-
ology (quantitative PCR, next generation sequencing platforms,
electrophoresis), which also supports other institutes, is also lo-
cated at the IEC.
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The Institute for Chemistry and Bioanalytics (ICB) provides
research in synthesis and medical chemistry, nanomaterials and
surfaces molecular nanotechnology, process engineering and
technology, in vitro diagnostics, DNA and RNA diagnostics, pro-
tein and tissue engineering, cell biology and toxicology as well
as instrumental analytics.
A large analytical platform for nanomaterials and surfaces
molecular nanotechnology such as a variety of microscopes (e.g.
TEM, SEM, EDX, AFM, infrared- and Raman imaging, LEXT),
spectroscopy and other technologies (e.g. µCT) is located in the
group of Prof. Dr. Uwe Pieles and were described already last
year in an article about material sciences.[1]
DNA and RNA diagnostics, cell biology and toxicology focus
on molecular techniques such as qPCR or NGS. This platform is
highly cooperative and overlaps with the platform at the Institute
of Ecopreneurship (IEC).
For the development of point of care devices (for in vitro diag-
nostics), surface plasmon resonance and bio-layer interferometry
play a key role as analytical tools. Therefore, a dedicated plat-
form for the analysis of protein–ligand interactions exists as well.
The group of Prof. Dr. Götz Schlotterbeck represents the
main analytical research and runs the instrumental analytical in-
frastructure of HPLC, GC, LC-MS, GC-MS and NMR (400MHz
NMR, LC/GC single quads, LC/GC triple quad, GC-TOF, LC-Q-
TOF, LC - Ion Trap and OrbiTrap). These techniques are not only
support for the other groups within the institute and FHNW (e.g.
for medical chemistry or chemical engineering), also analytical
research and training for diagnostics, food and environmental
analytics, structure elucidation, metabolomics and proteomics is
done there. The following exemplary projects show some typical
collaborations between external partners and several institutes
in analytical chemistry and are exemplary for the research per-
formed at FHNW.
Targeted, Correlative Single-cell Proteomics and
Metabolomics
The characterization of the metabolite and protein expression
on a single-cell level are important to understand the underlying
mechanisms of cellular processes. Picking, lyzing and spotting
of the content of single cells on the surface of microscope slides
was introduced by the team of Prof. Dr. Thomas Braun at Uni
Basel (C-Cina, Biozentrum).[2,3]A self-made interface based on a
TLC-MS interface (CAMAG, Muttenz, BL) was used to extract,
transfer and detect a few metabolites (glutamic acid, glutamine
and dopamine) by LC-MS down to single cell level. The pro-
teins remaining on the glass slide were antibody stained (thanks
for support of Dr. Gregor Dernick, F. Hoffmann-La Roche). The
antibody staining is still possible after the metabolite extraction
and analysis by LC-MS from the same cell thus enabling a cor-
relative analysis.
The results of this fundamental proof of concept study are
shown in Fig. 1. This project was supported by SNF project
200021_162521 (for the cell picker development) and nano ar-
govia A.9.12 (for mass spectrometry interface and Roche col-
laboration on visual proteomics) as well as an internal FHNW
collaboration of ICB and IPT.
Automated Dried Blood Spot Analysis for Newborn
Screening
All approx. 80’000 newborns in Switzerland are screened for
a list of serious genetic and metabolic disorders. Early diagnosis
of those conditions can help prevent their further development,
which untreated can result in brain damage, organ damage, and
even death (www.neoscreening.ch). The dried blood spots (DBS)
are sampled on-site by a nurse and analyzed in a centralized
laboratory.[4] To optimize the process and the sample tractabil-
ity, a fully automated DBS extraction system for online mass
spectrometry coupling was developed by CAMAG (https://dbs.
camag.com/dbs-ms-500; Fig. 2). In a joint effort between the
University of Applied Sciences FHNW, the newborn screening
laboratory of the children’s Hospital Zürich and CAMAG, a new
mass spectrometry-based screening method for amino acids, ac-
ylcarnitins, and steroids was developed and implemented (CTI
Project: 16898.1 PFLS-LS).[5–7]
Fig. 1. Left: The visual appearance of the used SH-SY5Y (neuronal
cells). In the middle, mass spectra of single cell metabolites by LC-MS
(targeted triple quad). Right: The remaining proteins on the microscope
slide detected by fluorescent antibodies in an IR-scanner.
Fig. 2. a) The CAMAG DBS-500 auto-sampler for DBS cards; b) func-
tion scheme of the imaging, extraction process and online external
analysis using chromatographic separation and mass spectrometric
detection (chromatography and mass spectrometry are not part of the
system shown in a)
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Personalized Life Style Guiding by Minimum Volume
Blood Analysis
This CTI project (18365.2 PFLS-LS) was a collaboration of
the startup Sanalytica GmbH/Baze (www.baze.com), the pro-
teomics laboratory Biognosy AG (www.biognosys.com) and the
diagnostic laboratory SwissAnalysis AG (www.swissanalysis.
ch). The main idea was to support a healthy lifestyle with fre-
quent blood testing, using a minimum amount of blood, sampled
at home. This frequent testing allows to monitor the effect of a
healthy lifestyle and supplementation strategy beyond the classi-
cal blood testing at the doctor’s surgery. Methods for fatty acids
by GC-MS (FHNW ICB), for vitamins and proteins by LC-MS
(FHNW ICB and Biognosy AG) as well as trace elements by
ICP-MS (FHNW IEC) were developed. All specialized methods
focused on small blood volumes and potential automation, which
were finally implemented by SwissAnalysis AG.
The TAP device (www.7sbio.com) was implemented to col-
lect approximately 100 microliter of blood at home. The samples
were shipped (cooled) to the laboratory, prepared and analyzed
by the parallel methods. The results are transferred and displayed
in an app, including tips for nutrition and supplement (by Baze).
The concept is shown in Fig. 3.
Gene Expression Analysis in Honey Bees after
Exposure to Pesticides
Honey bees, wild bees, and other insects are important pol-
linators and thus contribute to securing our food supply and pro-
mote biodiversity. In recent years, there has been a sharp decline
in the number of insects and an increased mortality rate among
bee colonies.[8] Several factors are responsible for this, including
exposure to pesticides.[9] It is known that exposure to pesticides
causes sublethal, chronic effects in honey bees in addition to
acute toxic effects. For example, memory formation, orientation
and flight behavior are negatively affected.[10] To identify the un-
derlying mechanism of action, honeybees are fed in the labora-
tory of FHNW with sugar syrup containing pesticides and gene
expression is analyzed after 1, 2 and 3 days of exposure using
quantitative PCR and next-generation sequencing (Fig. 4).[11] In
joint projects between the FHNW and Agroscope, the molecular
mechanism of action of behavioral changes in honey bees after
exposure to pesticides is investigated. The exact exposure con-
centrations are determined in the sugar syrup by using HLPC
coupled with MS.[12] Honey bee research at FHNW was initially
a collaboration with the Federal Office for Agriculture and the
Federal Office for the Environment. Current running projects are
partially granted and in collaboration with Agroscope.
ZHAW Wädenswil
The Institute of Chemistry and Biotechnology (ICBT) was
founded in 2016 as a result of a merger of the former Institute
of Chemistry and Biological Chemistry and the Institute of
Biotechnology. About 180 lecturers, researchers and scientific
staff work at the ICBT. Over 240 students are enrolled in the two
Bachelor programs, and more than 70 students in the two Master
programs. The ICBT is active in teaching and third-party funded
applied research to about the same extent. Many of its research
projects have a strong international orientation.
The convergence of biological and chemical sciences results
in strong synergies between the institute’s research groups and
a very broad scope in applied research. Our understanding of
chemistry and biotechnology is that it involves the linking of dis-
coveries in the natural sciences with technological knowledge,
with the aim of applying biological systems to the analysis and
manufacture of products.
In any case, a very sound understanding of analytical methods
and instrumentation is required in the different ICBT working
groups, even if they do not solely focus on the application and
optimization of analytical methods. As a brief and non-compre-
hensive overview, selected examples of research groups who ap-
ply advanced analytical tools to pursue their activities in applied
research are given below. The Centre for Functional Materials
and Nanotechnology employs analytical techniques such as scan-
ning electron microscopy (SEM/EDX), atomic force microscopy
and confocal Raman spectroscopy to characterize surfaces and
interfaces (for a review, see ref. [1]). In the Centre of Molecular
Biology and Microbiology, among other analytical and bioana-
lytical methods, matrix-assisted laser desorption/ionization time-
of-flight mass spectrometry (MALDI TOF-MS) of the newest
generation is used for the identification of microorganisms and
the qualitative analysis of (bio)macromolecules. The Centre for
Biochemistry and Bioanalytics applies high-resolution LC-MS/
MS (ESI-Q-TOF) to generate information about sequences and
post-translational modifications of proteins. Mass spectrometry,
Fig. 3. Concept of home sampling and testing. The TAP device is send
to the laboratory for analysis (amino acids, vitamin D/E, and proteins
by LC-MS, fatty acids by GC-MS, and trace elements by ICP-MS). The
results are displayed online or by app to adjust the diet and supplement
strategy.
Fig. 4. Graphical overview of honey bee exposure. Honey bee workers
are exposed with sugar syrup containing pesticides for 1, 2 and 3 days
followed by gene expression analysis in the brain and chemical analysis
of exposure solution.
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capillary electrophoresis and ion chromatography are used to
analyze complex glycosylation patterns of recombinant proteins.
Ligand–analyte interactions are examined in label-free real-time
measurements using surface plasmon resonance spectroscopy.
Many of ICBT’s research groups are dedicated to chemical
and biochemical engineering and bioprocess technology. These
groups make use of process analytical methods, such as inline
spectroscopy (IR, NIR, Raman, UV/Vis, fluorescence, for de-
tails see ref. [13]), inline particle measurements (focused beam
reflectance measurement, photon density wave spectroscopy), or
analytical methods that are coupled online to bioprocesses, such
as flow cytometry and HPLC.
In the following, a brief overview of the research activities
and selected projects in the Centre for Analytical Chemistry is
given. Here, four different research groups dedicate their work
to the development and application of analytical methods. The
Analytical Technologies group is engaged in developing and vali-
dating analytical methods with a focus on chromatography, mass
spectrometry and time-resolved real-time technologies, with a
particular emphasis on statistical data analysis and chemomet-
rics. Attached to the Analytical Technologies group, the Coffee
Excellence Center is a leading public research group in the field
of coffee. Together with worldwide partners, it works on proj-
ects along the entire value chain of coffee. The Environmental
Analysis group is concerned with identifying and quantifying
organic substances and chemical elements in environmental
samples and materials at trace levels. In the Measurement and
Sensor Technology group, sensors and other analytical methods
are developed and applied that are suitable for online monitor-
ing and control of (bio)processes. The Physical Chemistry group
focuses on molecular spectroscopy in the infrared (IR, NIR) and
UV spectral range and electrochemical methods.
Analytical Technologies
The groups for Analytical Technologies and the Coffee
Excellence Center are closely connected while having dis-
tinct and complementary orientation. The group for Analytical
Technologies is dedicated to developing and refining state-of-the
art analytical technologies with a focus on direct-injection real-
time mass-spectrometry of mostly volatile organic compounds
(VOC).Analytical technologies including couplings to processes
and data analysis are at the center of the research effort. In this
context, the two key technologies are proton-transfer-reaction
time-of-flight mass spectrometry (PTR-ToF-MS),[14,15] and ion-
mobility time-of-flight mass spectrometry (IM-ToF-MS).[16] In
the following an example of a technological development in the
fields of PTR-ToF-MS and IM-ToF-MS are outlined.
Development of Improved Nose-Air Sampling Technology
by PTR-ToF-MS
Analyses of mouth and nose-spaces have been used abun-
dantly in research over the past few decades for medical pur-
poses as well as for sensory analysis.[17–19]All of these sampling
methods have been using the analysis of the respiratory flow to
determine the content of volatiles present in the lungs, the mouth
or the nasal cavity. With regard to sensory analysis, this means
that the compounds of interest that accumulate in the mouth and
nasal cavity become diluted by the respiratory flow, leading to
low signal intensities and consequently only a limited number of
flavor active compounds can be monitored. Hence, one aspect of
the research in our laboratory is to increase the signal intensity
when sampling VOCs present in the mouth cavity.
To this end, we have tested, compared and optimized three
different samplingmethods: (i) Nose-space sampling of the exha-
lation stream (with nose-piece); (ii) mouth-space sampling of the
exhalation stream, using a Buffered End-Tidal breath sampling
inlet (BET) by Ionicon; (iii) direct mouth-space: drawing sample
gas directly from the mouth cavity while breathing through the
nose - mouthpiece from BET (non-re-breathing mouthpieces)
coupled to a sampling and dilution lance.[20] A schematic of this
setup is shown in Fig. 5.
The measurements of seven different coffees have revealed
the same order of magnitude in differences between the three
sampling methods. Fig. 6 shows two series of graphs. The se-
ries to the left depicts the intensities for m/z 153.055 and m/z
153.091, tentatively identified as vanillin and ethylguaiacol re-
spectively, which represent signals with the lowest intensity that
were still distinguishable from the background. The series to the
right shows the intensities of m/z 73.065, m/z 87.080 and m/z
101.0S60, tentatively identified as 2-methylpropanal, 2-/3-meth-
ylbutanal and 2,3-pentadione respectively, which represent sig-
nals with high intensities.
In summary, the signal area of our new direct mouth-space
sampling method was at least a factor of 5 higher in intensity,
compared to the indirect mouth-space sampling and a factor of
at least 20 higher compared to nose-space sampling.



































Fig. 6. Comparison of signal intensities of low intensity compounds (to
the left) and high intensity compounds (to the right) for three different
sampling methods: Upmost panels: nose-space; Middle panels: BET
mouth-space; lowest panels: direct mouth-space.
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The results from the comparison of the three different sam-
pling methods have shown a massive improvement in signal
intensity of the newly developed direct mouth-space sampling
compared to the other two (conventional) sampling methods. The
improvement in signal intensity can be directly linked to the fact
that this approach uses a direct sampling of the volatiles pres-
ent in the mouth-cavity instead of indirectly sampling these in
the exhalation stream. It therefore enables the sensitivity of the
measurement to be increased under otherwise equal conditions
such as time resolution and a given measurement setup. Thereby,
the direct mouth-space method enables a more sensitive dynamic
measurement of volatiles during the aftertaste or lingering phase
following the ingestion of food or drinks.
Online Analysis of Coffee Roasting with Ion Mobility
Spectrometry–Mass Spectrometry (IMS–ToF-MS)
Online analysis of coffee roasting was performed using ion
mobility spectrometry–mass spectrometry (IMS–MS) with co-
rona discharge ionization. This is the first time that the formation
of volatile organic compounds (VOCs) during coffee roasting was
monitored using ionmobility spectrometry, in positive and in neg-
ative ionmode.[16]The temporal evolution of more than 150VOCs
was monitored during the roasting of Brazilian Coffea arabica.
Mass-selective ion mobility spectrometry allowed a separation of
isobaric and isomeric compounds. In positive ion mode, isomers
of alkyl pyrazines were found to exhibit distinct time-intensity
profiles during roasting, providing a unique insight into the com-
plex chemistry of this important class of aroma active compounds.
Negative ion mode gave access to species poorly detectable by
other online methods, such as acids. In this study, the release of
fatty acids during coffee roasting was investigated in detail. These
increase in the early phase of the roasting process, followed by
a decrease at the later phase, as other VOCs start to be formed.
Normalized ion mobility spectra of some fatty acids are
shown in Fig. 7. For fatty acids with the same number of carbon
atoms, the IMS peaks shift to shorter drift times with increas-
ing number of double bonds, indicating a smaller collision cross
section for the unsaturated fatty acids. In contrast, prolonging
the chain length of the fatty acid increases the drift time and cor-
respondingly the collision cross section.
Within this study it was shown that corona discharge coupled
to IMS–MS is a powerful tool for online analysis of the temporal
evolution of volatile organic compounds, demonstrated here dur-
ing coffee roasting. The method exhibits two main advantages:
First, the ion mobility dimension separates based on collision
cross section, which often resolves isomers and isobars that can-
not be separated by MS alone. This was demonstrated for alkyl
pyrazines, which make different coffee aroma contributions de-
pending on their alkyl chain lengths and positions, as well as for
free fatty acids as discussed here (Fig. 7). The ion mobility spec-
tra showed that multiple isomers often contribute to single mass
peaks. This is a huge step ahead in comparison to prior direct inlet
online monitoring methods which are unable to separate isomers.
Second, the corona ion source provides easy and straightforward
access to both positive and negative ions, while prior online
methods are restricted to positive ions. This allows the routine
observation of a much larger range of chemical species.
Coffee Excellence Center
While the Coffee Excellence Center builds on the expertise
and infrastructure on the analytical technology group, its mission
is to advance our understanding of coffee, secure its future and
support a sustainable grow of the coffee sector along the whole
value chain through research, knowledge building and outreach.
From an educational perspective, its goal is to demonstrate the
application side of analytical technologies in one specific field
of research.
Hence, our research includes investigation of coffee along the
whole chain from the seed to the cup. In Fig. 8, PTR-ToF-MS
profiles of green coffee, roasted whole bean coffee, roast and
ground (R&G) coffee and finally of a coffee brew are shown, all
plotted on an identical intensity scale. PTR-ToF-MS is an emerg-
ing analytical technique that has first been applied by Yeretzian
and co-workers (since 1997) to coffee aroma analysis and is to-
day an established technique in the field.[14] While green coffee
shows a distinctively different profile of much lower intensities
than roasted coffee, grinding the roasted beans leads to a strong
increase of the volatile intensities.
The past 10 years have proven that the Coffee Excellence
Center is responding to a strong need of a growing and flourish-
ing coffee industry. Today the Coffee Excellence Center is work-
ing in collaborative projects with most large and multinational
companies. In this process, we also take the role of consultants
and partners in helping formulate and crystalize their strategies
and pipelines. Our involvement and deep knowledge of large
number of key actors of the sectors puts us in a unique position,
overseeing and understanding trends and opportunities.
Environmental
One of the main research activities of the Environmental
group lies in the field of elemental analysis and speciation.
Among other analytical methods, inductively coupled plasma-
optical emission spectrometry (ICP-OES), atomic absorption
Fig. 7. IMS spectra of mass peaks corresponding to free fatty acids
show multiple isomers/isobars. From bottom to top: c16:0 (m/z 255.22),
c18:2 (m/z 279.22), c18:1 (m/z 281.24), c18:0 (m/z 283.25), c20:0 (m/z
311.28), c22:0 (m/z 339.32).
Origin Transformation Release
Roasting Grinding Brewing
Fig. 8. PTR-ToF-MS mass spectra profiles of coffee as green whole
beans, roasted whole beans, roast and ground beans and coffee brew.
The volatiles of ground coffee clearly show the strongest overall intensi-
ties.
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spectroscopy (AAS), and wavelength-dispersive X-ray fluores-
cence (WD-XRF) are used. A project to prevent fuel abuse and
unauthorized burning of wood was conducted with the regional
governments of central Switzerland and the two federal offices
of Energy (BFE) and of the Environment (BAFU). Based on the
project results, benchmarks to limit heavy metals in wood incin-
eration ash were established.A long-term project with the «Spiez
Laboratory» focuses on the monitoring of military legacies, i.e.
sites contaminated with toxic heavy metals in Switzerland or
conflict areas in other parts of the world.
In a collaboration with Empa, organic pollutants that are used
as flame-retardants in polystyrene, were investigated. These in-
clude hexabromocyclodecanes (HBCDs) and chlorinated paraf-
fins (CPs), as well as their transformation and degradation prod-
ucts. Due to their high bioaccumulation potential and suspected
cancerogenic properties, these substances are regulated under
the Stockholm Convention list of persistent organic pollutants.
However, longer chain chlorinated paraffins are used as substi-
tutes with yet unknown transformation products. Considering the
various structural isomers of the chloroparaffins, the challenging
quantitative determination of these compounds was successfully
achieved using LC-MS/MS and LC-QTOF-MS.[21]
Measurement and Sensor Technology
In the Measurement and Sensor Technology group, sensors
and related online measurement techniques are developed, opti-
mized and applied to various processes, with a special focus on
parameters relevant in bioprocess monitoring and control. In these
processes, specific requirements have to be taken into account,
such as long-term stability, robustness in cleaning and sterilizing
procedures, or biocompatibility of materials used. For the bio-
technological cultivation of cells and microorganisms, single-use
systems have been increasingly used in recent years.As this offers
new challenges and perspectives in sensor technology, single-use
sensors are among the relevant research topics of the working
group. In the following, selected projects are presented. For con-
fidentiality reasons, no details can be given, since most of these
projects were carried out in collaboration with industrial partners.
For parallel and rapid bioprocess development, small bioreac-
tors are increasingly being used, but these offer only limited in-
stallation space for sensors. Therefore, robust sensors for critical
process parameters (such as the pH value and the concentration
of dissolved oxygen, dO) are required that meet the size con-
straints of these bioreactors, while still adhering to standardized
dimensions of sensor ports. In a project in collaboration with the
Bern University of Applied Sciences and an industrial partner,
a sensor that combines pH and dO measurement in a slim de-
sign was developed and evaluated. Whereas the pH value was
measured potentiometrically with a classic glass electrode, an
optical measuring method was used to measure the concentration
of dissolved oxygen. The optical sensor was based on an immobi-
lized dye that changes its fluorescence properties due to selective
quenching upon interaction with molecular oxygen. In the course
of the project, new features of the sensor were realized, such
as a special glass membrane, a light guide, an immobilization
technique for the optical sensor material, and the measurement
electronics. The built prototypes were evaluated in bioprocesses
and compared with other sensor systems. The innovative pH/DO
sensor proved to combine the advantages of the potentiometric
pH electrodes (high measuring range and robustness) with the
benefits of optical dO measurements (high stability and low
maintenance requirements).
The concentration of viable biomass is one of the most rel-
evant parameters in bioprocess control. For example, online mea-
surement of biomass concentration or viable cell density allows
to control the culture conditions or to determine the moment of
induction of the production of a recombinant protein. Although
offline methods to measure biomass concentration exist, they are
time-consuming, may be inaccurate and bear the risk of contami-
nation.As an alternative, dielectric spectroscopy has proved to be
a valuable tool for real time and in situmeasurements of biomass
concentration. However, this measurement technique is still rela-
tively new, and therefore, the prospects and limits of new applica-
tions in bioprocesses have yet to be investigated and understood.
In a collaboration with an industrial partner, a sensor based on
dielectric spectroscopy was applied to BHK cells grown on poly-
meric microcarriers. Cultivations on microcarriers are especially
critical in this respect, as they do not allow the use of optical
measurement techniques due to the light-scattering properties of
the beads. The investigations showed a very high correlation be-
tween online and offline measurements, therefore proving that it
is possible to analyze viable cell density of mammalian cells on
microcarriers in real-time.[22]
In another project in collaboration with the Institute for
Bioprocessing and Analytical Measurement Techniques
(Heiligenstadt, Germany), dielectric spectroscopy was used to
monitor the growth of hairy root cultures (Fig. 9). Up to now, the
growth of these plant organ cultures can only be monitored by
applying time-consuming and destructive methods, such as the
determination of the dry cell weight. The measurements proved
that dielectric spectroscopy can be successfully applied not only
to cell suspensions, but also to organ cultures.[23]
In a project in collaboration with the Swiss Federal Institute of
Metrology, a newactivity scale for sodium, potassium,magnesium,
calcium and chloride ions was proposed. This will allow ion activ-
ity measurements of these physiologically relevant ions with high
Fig. 9. As the spatial distribution of Hairy Root biomass is not ho-
mogeneous, online measurement of these cultures is challenging.
Nevertheless, the sensor signal (a characteristic frequency dependent
drop of capacitance Cp) can be correlated to the cultivation time.
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comparability and traceability, independent from themeasurement
systems utilized. This is one important prerequisite for safe and
efficient measurements of these ions in clinical laboratories based
on ion-selective sensors and other methods. To prove this concept,
the Measurement and Sensor Technology group successfully par-
ticipated in an interlaboratory comparison, in collaboration with
several leading European metrology institutes (Fig. 10).[24]
HEIA-Fribourg
The analytical platform of the Institute of Chemical
Technology (ChemTech) at HEIA-Fribourg is formed by several
professors working in different fields of chemical characteriza-
tion, and includes anAnalytical Laboratory Service. Its main pur-
pose is to provide strong support to the ChemTech Institute and
to the training of our students. The laboratories at HEIA-Fribourg
are well equipped with all the essential instrumentation in ana-
lytical chemistry (LC, GC, MS, ICP-OES, NMR…), as well as
physical chemistry (DSC, TGA, Raman spectroscopy, rheology,
Particle Size Distribution...).
Analytical Laboratory Service
From the start of its activity, the main objective of the
Analytical Laboratory Service at HEIA-Fribourg was to make
the institute’s analytical infrastructure available to the largest
possible number of partners and to develop new collaborations
with various local economic players.
With more than 15 years of experience, the Service offers its
expertise and key skills to support the Institute’s strategic axe of
material characterization technology. In particular, it is active in
the fields of NMR spectroscopy, gas and liquid chromatography
coupled with mass spectrometry, dynamic scanning calorimetry,
EDX analysis with a scanning electron microscope and Raman
spectroscopy (Fig. 11)).
The Analytical Laboratory Service is facing increasingly
more diversified and sophisticated demands, coming primarily
from internal R&D projects of the Swiss Universities ofApplied
Sciences, but also from external, national industry partners.
The Service has built and maintained long-term, strong re-
lationships with its key clients. For example, the Laboratory is
performing a part of the quality control process for a designer
and manufacturer of hyaluronic acid dermal fillers and skincare
products by measuring density and refractive index. Metalor
Technologies SA – a leading participant in the field of precious
metals and advanced materials (www.metalor.com) - is a part-
ner with whom the Laboratory works together on HPLC reac-
tion monitoring. As a last example, the Service collaborated with
the R&D laboratory of a well-known watchmaker on molecular
structure determination by NMR.
Analytical Chemistry R&D
The ChemTech Institute participates in several projects with
other Universities ofApplied Sciences, especially in the environ-
mental chemistry field. A recent project, named ‘Xyloclean’ and
carried out with Prof. R. Röthlisberger from HEIG-VD, aimed
to minimize the polluting emissions from wood combustion. For
this purpose, the residual HAPwere quantified in the emitted par-
ticulate matter using GC-MS and a specific extraction technique.
The Institute is now involved in a new project called
‘Conforto’, in collaboration with HEPIA-GE and Prof. B. Oertli.
This project deals with a multi-disciplinary approach to design
a new concept of urban water basins with multiple ecosystem
services (biodiversity protection, flood regulation, refreshing ef-
fect…). The role of the Institute’s analytical platform will be to
support the evaluation of the impact of specific urban pollutants
and to study the potential use of these basins for water treatment.
The carbon-trapping capacity of these ponds will also be assessed
by looking analytically at the CO
2
exchanges.
In the field of instrumental chemistry, ChemTech is active
in the conception, development and production of affordable in-
struments. This field of research started about ten years ago with
the construction of a budget capillary electrophoresis (ECB) de-
signed for the detection of counterfeit medicines.[25]
Building on this experience, the team is now developing a
new generation of capillary electrophoresis instrument based on
the open-source hardware principle, and looking for new applica-
tions for this technology.
Finally, a budget Raman instrument (RAB) was also devel-
oped with the idea to offer a portable screening capability to sup-
port the identification of counterfeit drugs directly in the field.[26]
Physical Chemistry R&D
Over the past 3 years, a special effort has been made at
ChemTech to develop skills in the field of powder characteriza-
tion. For this purpose, various student projects have been carried
out in order to study the behavior of certain food powders. In par-
ticular, the water absorption process and its effect on the physical
properties of the powder has been investigated. In addition, phe-
nomena such as oxidation and degassing in roast & ground coffee
have also been studied. The recent acquisition of an instrument
to measure the kinetics of solid sample water intake should allow
the Institute to increase our skills further in this area.
PAT & bio-PAT
The ChemTech Institute at HEIA-FR is active in the area of
Process Analytical Technology (PAT), applied to both chemistry
and bioprocessing.[13] PAT, an initiative proposed by the FDA in
2004, is a systematic analytical approach to designing, analyzing
and controlling a process through timely measurements of criti-
cal quality and performance attributes, with the goal of increasing
process understanding and ensuring final product quality.
The PAT strategy is very useful, for instance, in the field of
continuous flow chemistry. Micro- and meso-reactor technology
offers many advantages, such as rapid heat and mass transfer, and
it has been studied actively at ChemTech over the past several
years. In a recentMaster project, carried out in collaboration with
the fine chemicals industry, the integration of an online process
Fig. 10. Selected results of an interlaboratory comparison based on
measurements of ion activities of Mg2+ and Ca2+ ions. Reference values
are displayed in red color, activity values measured by ZHAW are de-
picted in column 4.
Fig. 11. The Analytical Laboratory Service.
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supervision platform in a mini-CSTR reaction screening system
was investigated.[27] The system was designed such that different
process monitoring probes (IR, Raman, etc.) could be installed
interchangeably, depending on the need, providing a live analyti-
cal window into the process and enabling process development,
control and optimization.
Several projects have also been conducted on the application of
PAT in the field of bioprocess engineering. In one study, online bio-
mass monitoring sensors were used to control the specific growth
rate of microorganisms and to prevent the production of undesired
overflow metabolites.[28] From the control point of view, this task
is difficult because of the strong noise present in the online bio-
mass concentration signal and due to the non-linear dynamics of
the process. In the latest study, a new controller logic was proposed
to address these problems.[29] The application of calorimetry as a
PAT tool in bioprocessing is currently being investigated.
HES-SO Sion
The Institute of Life Technologies (ITV) is part of the
School of Engineering of the HES-SO Valais-Wallis. Analytical
Chemistry, Biotechnology and Food Technology are the three
educational pillars of the Bachelor of Science degree program
while Biotechnology & Sustainable Chemistry, Diagnostic
Systems, Food & Natural Products as well as Peptide & Protein
Technologies constitute the four research groups of the Institute.
Various platforms, such asAnalytical Chemistry&Biochemistry,
strategically support the research groups with a portfolio of spe-
cialized high-end equipment, analytical methods, and expertise.
A strong experience in analytical chemistry, cell cultures and
purification methods, especially in the area of downstream pro-
cessing (DSP), is at hand. In addition, one of the internationally
leading laboratories in modern separation sciences and its ap-
plications is present at ITV. The highly qualified staff of ITV
is organized in interdisciplinary, matrix-like research teams and
works with high confidentiality, if requested. ITV has 2,200 m2
of modern laboratories and pilot plants including a large set of
wave bags and bioreactors up to 300 L. The platforms offer their
services and know-how to industry partners such as companies
from the biopharmaceutical sector. All platforms have a long and
successful record of accomplishment in commissioned work for
companies and scientific/applied science projects.
The comprehensive and modern analytical instrument park at
ITV is organized as an analytical platform. It provides efficient
support in scientific but also industrial projects and is accessible
for contract work of industrial partners of ITV. The Analytical
Platform works – if needed – under the quality management sys-
tem ISO 17025, the microbiology section under GMP. Based on a
long-termconventionbetween theFederal Institute ofTechnology
in Lausanne (EPFL), their pole ‘EPFLValais-Wallis’ in Sion and
the HES-SO Valais-Wallis, Sion, ITV has internal access to the
high-end analytical instruments of the EPFL, which also leads to
close scientific cooperation. Furthermore, the analytical labora-
tory of ITV functions asAgilent Technologies CH demonstration
laboratory for analytical equipment and applications.
At the beginning of 2021, ITV including the Analytical
Platform is moving to its new building at the new and mod-
ern HES-SO Valais-Wallis campus next to the EPFL common
pole ‘Energypolis’, directly located at the train station of Sion.
Hereinafter we present R&D project examples where the analyti-
cal chemistry & biochemistry platform was crucial in attaining
project objectives.
The Analytical Platform at the Institute of Life
Technologies: Examples of Established State-of-the-
art Bioanalytical Applications
Proteins, particularly monoclonal antibodies (mAbs) are an
important class of biotherapeutics. They have a strong presence
and sustained growth in the pharmaceutical industry nowadays.
About 70 mAbs have received first approval for human treat-
ment in Europe, two in 2020.[30] They are used for a variety of
indications including several forms of cancer, autoimmune and
infectious diseases. Research on mAbs, but also on antibody-
like compounds as for example, bispecific antibodies (bsAbs) or
single chain variable fragments (scFv) and particularly antibody
drug conjugates (ADC) is a growing field. Due to the upcoming
patent expiry of top-selling originator products, more and more
biosimilars are under development. Especially for the biosimilars
comprehensive analytical characterization is needed in order to
detect modifications in comparison to the originator, e.g. in the
amino acid sequence or post translational modifications (PTM)
as the glycosylation pattern, which may impact therapeutic ef-
ficacy, bioavailability and biosafety.[31]
To be able to characterize complex biomolecules like mABs
the Institute of Life Technologies has established many state-of-
the-art bioanalytical tools and techniques in the last years. They
allow the development as well as the quality control of e.g. com-
plex proteins to be monitored, including posttranslational modi-
fications. Among many others, capillary gel electrophoresis, en-
zymatic sample preparation techniques, conventional as well as
special LC techniques and mass spectrometry are present.
Capillary Gel Electrophoresis (CGE-SDS)
For many years, conventional sodium dodecyl sulphate–poly-
acrylamide gel electrophoresis (SDS-PAGE) has been widely
used to monitor identity and purity of therapeutic proteins.[32,33]
At theAnalytical Platform at the Institute of Life Technologies in
addition to the traditional SDS-PAGE, also CGE-SDSwas imple-
mented for the analysis of proteins, especially mAbs.Advantages
of CGE-SDS in comparison to SDS-PAGE include short analysis
time, high reproducibility, and much higher resolution. It is less
laborious, does not use toxic chemicals and has the possibility
of full automation using an autosampler. Proteins are detected
on-capillary, usually with UV light at 220 nm. The sensitivity
is comparable to the Coomassie blue staining method. In high
sensitivity impurity assays, proteins can be detected down to
about 10 ng/mL after labelling with a fluorescent dye and using
a laser-induced fluorescence detector (LIF). This sensitivity is
similar to that achieved by using silver staining in SDS-PAGE.
In Fig. 12 the analysis of an intact, non-reduced immunoglobulin
(IgG) sample by CGE-SDS-UV is shown. 100 µg of protein were
buffer exchanged to SDS-MW Sample Buffer (Sciex, SDS-MW
Analysis Kit) and alkylated with iodoacetamide at 70 °C for 5
minutes. Separation was performed with SDS-MWGel Buffer in
a 30 cm bare fused capillary at 15 kV on a ProteomeLab PA800
capillary electrophoresis system from Sciex.
This analysis is used to determine, for example, the mAb
content (titer) as well as its impurities such as lower molecular
Fig. 12. Electropherogram of an IgG sample produced at Institute of Life
Technologies and analyzed in the Analytical Platform laboratory; tenta-
tive peak assignment.
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weight fragments in a formulation. In addition, the percentage
of high molecular weight species, e.g. stable aggregates and the
percentage loss of one N-glycan chain or two N-glycan chains
from an intact humanized mAb, are assessed and monitored dur-
ing stability studies.
Mass Spectrometry (MS) Peptide Mapping
Bottom-up proteomics by proteolytic digestion of proteins
prior to MS analysis is a common approach to identify proteins
based on their amino acid sequence and to detect post-trans-
lational modifications. The general procedure of protein iden-
tification involves digestion of the intact protein using trypsin
or other proteolytic enzymes followed by mass analysis of the
resulting peptides. In general, tryptic digestion in solution is a
time-consuming process, which is easily tainted with operator’s
mistakes resulting in poor repeatability. In order to overcome
those drawbacks, a workflow including an easy-to-use and quick
digestion kit (Smart DigestTM, Thermo Fisher Scientific) with-
out tedious sample preparation prior to accurate MS analysis
(HPLC-qTOF 6530, Agilent) was established at the Institute of
Life Technologies. As a result, highly reproducible digestions
(RSD < 5 %, n = 3, 5 target peptides) were obtained with a
sequence coverage ranging from 71 to 99% for five model pro-
teins, including two different mAbs. Sample preparation time
was decreased substantially. Conventional in-solution tryptic
digestion takes about 16 h. Using the smart Digest™ approach,
digestion time takes 20 to 60min, depending on the protein com-
plexity. For example, in Fig. 13 bovine serum albumin (BSA)
was digested during 20 min leading to 96% of sequence cover-
age. The protein was separated on a HPLC 1260 from Agilent
equipped with a BioZen 2.6 µm Peptide XB-C18 column from
Phenomenex.
Intact Mass and Drug to Antibody Ratio (DAR)
Antibody drug conjugates (ADCs) are designed for targeted
treatment of a wide variety of cancers. These complex molecules,
composed of a monoclonal antibody linked to a small organic
biologically active cytotoxic (anticancer) payload or drug, bind to
a surface antigen of the cancer cell.After phagocytosis by the cell
the highly cytotoxic payload is release by e.g. lysosomal cleav-
age.[15] The number of payloads per antibody is one of many key
parameters that requires determination to ensure clinical efficien-
cy and safety for patients. To support industrial research projects
on bio-conjugation development and optimization at the Institute
of Life Technologies, a general workflow was established using
mass spectrometric techniques. It comprises the determination
of the intact mass of the native protein and the labelled one, the
comparison of both and finally the assessment of the number
of labels as well as the determination of the mean drug to an-
tibody ratio (DAR). An example is shown in Fig. 14. Based on
the masses detected from the unmodified and modified mAb, it
was found that in total five payloads were attached to the mAb,
three on the heavy chain and two to the light chain, leading to
a mean DAR of 3.3. Results could be confirmed by comparing
them to capillary isoelectric focusing (cIEF-UV) analysis of the
same samples (data not shown). The same pattern was obtained,
since cIEF separation is based on charge differences and with
each payload the mAb loses one positive charge.
To conclude, the Analytical Platform of the Institute of Life
Technologies possesses state-of-the-art and well-established ge-
neric workflows and a wide catalogue of methods and techniques
that enable the support of research projects in the area of charac-
terization and quality control of complex biomolecules.
The Analytical Platform Supports the Development
and Performance Evaluation of Next-generation
Point-of-care Diagnostic Systems
The Diagnostic Systems Research Group, for more than a
decade now, has worked on innovative solutions to address unmet
needs in the field of in vitro diagnostics (IVD) and more specifi-
cally point-of-care (POC) diagnostics.
The IVD domain is required to meet stringent quality stan-
dards, therefore, a specialized and powerful analytical platform
is necessary to ensure a detailed characterization of developed
assay reagents such as derivatized proteins, labeled antibodies
and modified nucleic acids (cf. Table 1) and to support valida-
tion of diagnostic test performance characteristics. One of the
gold standard reference methods in clinical laboratories is mass
spectrometry (MS).[34,35] Hence, we have established several liq-
uid chromatography (LC) coupled to MS methods ranging from
quantitative therapeutic drug monitoring (TDM) to qualitative
protein sequencing approaches for benchmarking purposes dur-
ing the development of POC diagnostic tests.
Asanexample in thecontextof theNano-Teraproject ISYPEM
II, a demonstrator was designed and developed for TDM of the
drugs Tacrolimus, Everolimus and Tobramycin by the Diagnostic
Systems research group in collaboration with the Systems
Engineering Institute in order to enable personalized, continuous
Fig. 13. Base peak chromatogram (BPC) of a tryptic digest of BSA
analyzed in the laboratory of the Analytical Platform ‘HES-SO Sion’
with a qTOF 6530 MS from Agilent Technologies. Elution was achieved
with a linear gradient of 5–70% solvent B in 90 min with a flowrate of
0.2 mL/min, where solvent A was MS grade water with 0.1% formic
acid and solvent B was MS grade acetonitrile with 0.1% formic acid.
An AJS ionization source was used and MS data were acquired in the
positive ion mode in the range of 100–3200 m/z at a rate of 1 Hz in
extended dynamic range (2 GHz) mode with a qTOF 6530 from Agilent
Technologies. Data were analyzed with BioConfirm software.
Fig. 14. Deconvoluted mass spectra of a mAbs heavy chain with dif-
ferent numbers of the small payload (left) and light chains with differ-
ent numbers of the small payload (right), analyzed with a qTOF 6530
from Agilent Technologies. The ADC was reduced with 5 mM DTT at
56 °C for 20 min to obtain the light and heavy chains. After dilution,
the sample was separated on a HPLC 1260 from Agilent equipped
with a BioZen 3.6 µm Intact XB-C8 column from Phenomenex. Elution
was achieved with a gradient of 5–95 % solvent B in 20 min and a
flowrate of 0.3 mL/min, where solvent A was MS grade water with
0.1% formic acid and solvent B was MS grade acetonitrile with 0.1%
formic acid. An AJS source was used and MS data were acquired in
the positive ion mode in the range of 100–3200 m/z at a rate of 1 Hz in
extended dynamic range (2 GHz) mode with a qTOF 6530 from Agilent
Technologies. Data were analyzed with BioConfirm software.
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and accurate monitoring of treatments. Measurements using the
POC diagnostic demonstrator device were performed within a
low-volume chamber equippedwith a compact optical reader, en-
abling drug quantification using a fluorescence polarization im-
munoassay (FPIA). Processing of blood samples obtained from
a finger prick were performed using a microfluidic cartridge.
To verify that the developed demonstrator met the challenging
analytical and clinical specifications,[33] results of tested samples
were compared to data obtained with LC-MS methods.[36,37]
Fig. 15 depicts the current stage of integration of the POC diag-
nostic device for TDM at the HES-SOValais-Wallis.
Another ongoing project is dedicated to the development of
an innovative POC diagnostic system in order to deploy in the
future a cost-effective, yet quantitative and accurate procedure
to support diagnosis of hypothyroidism with a quick TAT. The
time factor is critical in the context of neurocognitive and physi-
cal development disorder[38] that can occur when the disease is
not treated in the first hours of human life.[39,40] In developed
countries, it is usually possible to provide such diagnostic test-
ing within a well establish laboratory network. However, in re-
mote locations of large countries or in resource limited areas
of the world, the time between collection, transport, measure-
ment and finally diagnosis prior treatment can take at least three
days to weeks, which is too long to prevent irreversible brain
damage and growth deceleration to infants.[41] The HES-SO
Valais-Wallis activities have focused on providing the bioassay
based on a low-cost system and, at the same time, evaluating the
performance of existing solutions by direct comparison with a
quantitative LC-MS2 analytical method. Based on the support
given by the Analytical Chemistry & Biochemistry Platform it
was possible to determine the limited quantitative performance
of commercially available rapid tests and pinpoint challenges
towards a successful implementation of a next-generation POC
diagnostic system.
To promote the development of new and innovative POC
diagnostic solutions, the Diagnostic Systems Research Group
is organizing jointly with the Swiss Center for Electronics and
Microtechnology (CSEM) the 3rd Swiss Symposium in Point-of-
Care Diagnostic to take place inVisp,Valais on 29October, 2020.
This event brings together stakeholders from academia, research,
medicine and industry to foster innovation in diagnostics (more
information on our website: www.pocdx.ch).
Received: June 10, 2020
[1] P. Brodard, M. Dabros, R. Marti, E. Vanoli, M. Zinn, U. Frey, C. Adlhart, L.
Kind, F. Koch, F. Burgio, J. Stenqvist, S. Saxer, U. Pieles, P. Shahgaldian,
S. Wendeborn, Chimia 2019, 73, 645; doi: 10.2533/chimia.2019.645.
[2] S. Kemmerling, S. A. Arnold, B. A. Bircher, N. Sauter, C. Escobedo, G.
Dernick, A. Hierlemann, H. Stahlberg, T. Braun, J. Struct. Biol. 2013, 183,
467; doi: 10.1016/j.jsb.2013.06.012.
Table 1. Project examples requiring a reference analytical method for head-to-head comparison and performance verification.




Development of a compact POC diagnostic
demonstrator to perform reliable therapeutic drug
monitoring (TDM) based on FPIA.
LC-MS2 quantitative assay in whole blood as




Development of a compact POC diagnostic
demonstrator based on FPIA to conduct reliable
TDM for newborns.
LC-MS2 quantitative assay in whole blood as
reference method.
Cholesterol Development of a one-step colorimetric and
electrochemical IVD quantitative assay at the POC.
LC-MS2 quantitative assay in whole blood as
benchmark method.
Cortisol Development of a quantitative lateral flow assay. LC-MS2 quantitative assay in whole blood or
saliva as benchmark method.
Thyroxine (T4)
(endocrine analytics)
Proof of concept study of a POC device for
the diagnostic testing of hypothyroidism in
newborns.




Feasibility of a POC diagnostic device for
detection of Chlamydia infections based on
isothermal amplification and an LFA readout.
Quantitative Realtime PCR as reference method.
Mild Traumatic Brain
Injury (mTBI)
Development of an electrochemical POC
diagnostic device to diagnose mTBI on-site
ELISA IVD validated method
IgG/IgM COVID-19 Evaluation of the requirements to use POC diag-
nostic tests to support public health actions during
the deconfinement phase of COVID-19 outbreak.
IVD laboratory-based validated methods and
collaboration with clinical central laboratories.
Fig. 15. Sample-to-result workflow of the POC diagnostic system that
includes capillary blood collection (1), therapeutic drug extraction (2),
quantification of the drug content in a microchamber with a compact
fluorescence-polarization (FP) reader (3) and data processing on a se-
cured dedicated platform (4).
628 CHIMIA 2020, 74, No. 7/8 Columns
[3] C. Schmidli, L. Rima, S. A. Arnold, T. Stohler, A. Syntychaki, A. Bieri, S.
Albiez, K. N. Goldie, M. Chami, H. Stahlberg, T. Braun, J. Visual. Exp.:
JoVE 2018; doi: 10.3791/57310.
[4] a) J. V. Leonard, C. Dezateux, Paediat. Child Health 2011, 21, 56; doi:
10.1016/j.paed.2010.10.011; b) S. Sahoo, L. Franzson, J. J. Jonsson, I.
Thiele, Mol. bioSyst. 2012, 8, 2545; doi: 10.1039/C2MB25075F.
[5] R. Fingerhut, M. L. Silva Polanco, G. D. J. SilvaArevalo, M.A. Swiderska,
Rap. Commun.Mass Spectrom. RCM 2014, 28, 965; doi: 10.1002/rcm.6856.
[6] S. Gaugler, J. Rykl, I. Wegner, T. von Däniken, R. Fingerhut, G.
Schlotterbeck, Int. J. Neonatal Screen. 2018, 4, 2; doi: 10.3390/
ijns4010002.
[7] M. Luginbühl, S. Gaugler, Clin. Biochem. 2020; doi: 10.1016/j.clinbio-
chem.2020.02.007.
[8] D. Goulson, E. Nicholls, C. Botías, E. L. Rotheray, Science 2015, 347,
1255957; doi: 10.1126/science.1255957.
[9] J.-P. Faucon, L. Mathieu, M. Ribiere, A.-C. Martel, P. Drajnudel, S.
Zeggane, C. Aurieres, M. F. A. Aubert, Bee World 2002, 83, 14; doi:
10.1080/0005772X.2002.11099532.
[10] N. Desneux, A. Decourtye, J.-M. Delpuech, Ann. Rev. Entomol. 2007, 52,
81; doi: 10.1146/annurev.ento.52.110405.091440.
[11] V. Christen, M. Schirrmann, J. E. Frey, K. Fent, Environ. Science Technol.
2018, 52, 7534; doi: 10.1021/acs.est.8b01801.
[12] K. Fent, T. Haltiner, P. Kunz, V. Christen, Journal? 2020, submitted.
[13] M. Dabros, O. Vorlet, R. Marti, W. Riedl, G. Grundler, A. Vaccari, M.
Zinn, A. Ecker, C. Hinderling, Chimia 2015, 69, 482; doi: 10.2533/chi-
mia.2015.482.
[14] F. Biasioli, F. Gasperi, C. Yeretzian, T. D. Märk, TrAC Trends Anal. Chem.
2011, 30, 968; doi: 10.1016/j.trac.2011.03.009.
[15] F. Biasioli, C. Yeretzian, T. D. Märk, J. Dewulf, H. van Langenhove, TrAC
Trends Anal. Chem. 2011, 30, 1003; doi: 10.1016/j.trac.2011.04.005.
[16] A. N. Gloess, C. Yeretzian, R. Knochenmuss, M. Groessl, Int. J. Mass
Spectrom. 2018, 424, 49; doi: 10.1016/j.ijms.2017.11.017.
[17] J. A. Sánchez-López, A. Ziere, S. I. F. S. Martins, R. Zimmermann,
C. Yeretzian, J. Breath Res. 2016, 10, 36005; doi: 10.1088/1752-
7155/10/3/036005.
[18] D. Mayr, T. Märk, W. Lindinger, H. Brevard, C. Yeretzian, Int. J. Mass
Spectrom. 2003, 223-224, 743; doi: 10.1016/S1387-3806(02)00967-3.
[19] D. D. Roberts, P. Pollien, N. Antille, C. Lindinger, C.Yeretzian, J. Agricult.
Food Chem. 2003, 51, 3636; doi: 10.1021/jf026230+.
[20] M.Wellinger, S. Biollaz, J. Wochele, C. Ludwig, Energy & Fuels 2011, 25,
4163; doi: 10.1021/ef200811q.
[21] S. Crelier, O. Vorlet, P. Corvini, P. Lienemann, Chimia 2018, 72, 652; doi:
10.2533/chimia.2018.652.
[22] C. Demuth, I. Poggendorf, R. Lüthi, M. Frank, K. McNeel, Gen. Engin.
Biotechnol. News 2016, 36, 22; doi: 10.1089/gen.36.12.13.
[23] C. Demuth, T. Nacke, A. Barthel, I. Poggendorf, J. Varonier, M. Eggli, 18.
Heiligenstädter Kolloquium 2016, 2016.
[24] F. Bastkowski, P. Spitzer, R. Eberhardt, B. Adel, S. Wunderli, D. Berdat, H.
Andres, O. Brunschwig, M.Máriássy, R. Fehér, C. Demuth, F. B. Gonzaga, P.
P. Borges, W. B. da Silva Junior, A. Vosp lová, M. Vi arová, S. Srithongtim,
Accred. Qual. Ass. 2013, 18, 469; doi: 10.1007/s00769-013-1016-5.
[25] C. Rohrbasser, D. Rhême, S. Décastel, S. Roth, M. d. L. A. Montes,
J.-L. Veuthey, S. Rudaz, Chimia 2009, 63, 890; doi: 10.2533/chim-
ia.2009.890.
[26] J.-P. Bourgeois, O. Vorlet, Chimia 2018, 72, 905; doi: 10.2533/chim-
ia.2018.905.
[27] L. Albergati, Master thesis HES-SO, 2020.
[28] L. Habegger, K. Rodrigues Crespo, M. Dabros, Fermentation 2018, 4, 79;
doi: 10.3390/fermentation4030079.
[29] Y. Brignoli, B. Freeland, D. Cunningham, M. Dabros, Processes 2020, 8,
679, doi: 10.3390/pr8060679.
[30] H. Kaplon, M. Muralidharan, Z. Schneider, J. M. Reichert, mAbs 2020, 12;
doi: 10.1080/19420862.2019.1703531.
[31] M. Lies, C. Lew, R. Lakshmanan, A. Guttman, Drug Discov. Devel. AB-
Sciex 2018, 1.
[32] L. Zhang, B.Yeung, J. Liu, Am. Lab. 2006, 38, 34.
[33] A. Taddeo, D. Prim, J.-M. Segura, M. E. Pfeifer, J. Appl. Lab. Med. 2020, 5,
738, doi: 10.1093/jalm/jfaa067.
[34] S. E. Conklin, C. E. Knezevic, Clin. Biochem. 2020; doi: 10.1016/j.clinbio-
chem.2020.03.008.
[35] A. W. S. Fung, V. Sugumar, A. H. Ren, V. Kulasingam, J. Clin. Pathol.
2020, 73, 61; doi: 10.1136/jclinpath-2019-206269.
[36] F.Aucella, V. Lauriola, G.Vecchione, G. L. Tiscia, E. Grandone, J. Pharma.
Biomed. Anal. 2013, 86, 123; doi: 10.1016/j.jpba.2013.08.001.
[37] J. Dinéia Perez, D. Sanches Aragão, F. Aparecida Ronchi, A. C. Febba,
C. F. Rosso, H. Tedesco-Silva Junior, J. O. Medina de Abreu Pestana,
D. E. Casarini, Transplantation Proc. 2020; doi: 10.1016/j.transpro-
ceed.2020.01.077.
[38] M. D. Rappley, Med. Update for Psychiatrists 1996, 1, 64; doi: 10.1016/
S1082-7579(96)80028-8.
[39] A. J. Bauer, A. J. Wassner, Endocrine 2019, 66, 51; doi: 10.1007/s12020-
019-02024-6.
[40] F. Delange, Baillière’s Clin. Endocrinol. Metabol. 1988, 2, 637; doi:
10.1016/S0950-351X(88)80057-0.
[41] S.R.Rose,R. S.Brown,T. Foley, P.B.Kaplowitz,C. I.Kaye, S. Sundararajan,
S. K. Varma, Pediatrics 2006, 117, 2290; doi: 10.1542/peds.2006-0915.
